Newco news Palvella completes enrollment for rare disease study March 6, 2020 By Lee Landenberger No Comments Palvella Therapeutics Inc. has completed enrollment of its phase II/III trial for treating adults with pachyonychia congenita, a rare disease that eventually leads patients to a life of chronic pain and severe problems with walking.Read More